BRIEF-Immunogen says cash balance at Dec 31, 2016 was about $160 mln

* On January 11, 2017, company said that its cash balance at December 31, 2016 (unaudited) was approximately $160 million - SEC filing Source text (http://bit.ly/2jI3xFH) Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.